Measure of function in rheumatoid arthritis: individualised or classical scales? by Seror, Raphaèle et al.
Measure of function in rheumatoid arthritis:
individualised or classical scales?
Raphae`le Seror, Florence Tubach, Gabriel Baron, Francis Guillemin, Philippe
Ravaud
To cite this version:
Raphae`le Seror, Florence Tubach, Gabriel Baron, Francis Guillemin, Philippe Ravaud. Measure
of function in rheumatoid arthritis: individualised or classical scales?. Annals of the Rheumatic
Diseases, BMJ Publishing Group, 2010, 69 (1), pp.97-101. <10.1136/ard.2008.102137>.
<inserm-00376884>
HAL Id: inserm-00376884
http://www.hal.inserm.fr/inserm-00376884
Submitted on 20 Apr 2009
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
Ann Rheum Dis . Author manuscript
Page /1 8
Measure of function in rheumatoid arthritis: individualised or classical
scales?
Rapha le Seror è 1 2 * , Florence Tubach 1 2 3 , Gabriel Baron 1 2 3 , Francis Guillemin 4 , Philippe Ravaud 1 2 3
Mod les et m thodes de l valuation th rapeutique des maladies chroniques   1 è é 'é é INSERM : U738 , Universit  Paris-Diderot - Paris VII é , Facult
 de m decine Paris 7 16, Rue Henri Huchard 75018 Paris,FRé é
D partement d pid miologie, biostatistique et recherche clinique   2 é 'é é AP-HP , H pital Bichat - Claude Bernard ô , 46 rue Henri Huchard 75018
Paris,FR
Mod les et m thodes de l valuation th rapeutique des maladies chroniques  3 è é 'é é INSERM : E0357 , GH Xavier Bichat, 48, Rue H. Huchart,
75018, Paris,FR
Service d Epidemiologie Nancy  4 ' INSERM : UCIE6 , FR
* Correspondence should be adressed to: Rapha le Seror è <raphaele.se@gmail.com >
Abstract
Objective
The Health Assessment Questionnaire Disability Index (HAQ-DI) is the most widely used measure of function in rheumatoid arthritis
(RA). To enhance the incorporation of patients  view in outcome assessment, this study aimed to evaluate individualized forms of the’
HAQ-DI.
Patients and methods
HAQ-DI data were prospectively obtained from 370 RA outpatients treated with leflunomide over a 6-month period. At baseline and
final visits, patients had to rate the importance they attached to each activity addressed by the 20 HAQ-DI items, and to select the 5
activities they considered the most important. Different individualized scales were evaluated: scales preserving all domains, in which
the score for each item is multiplied by or added to its importance; and scales involving for each patient only the 5 most important
items. The psychometric properties of theses scales were compared to those of the HAQ-DI.
Results
For each HAQ-DI item, severity and importance scores were weakly correlated. Scores for all individualized scales were highly
correlated with the HAQ-DI score (rho>0.75). All scales had a good internal consistency (Cronbach s alpha: 0.87 to 0.88). Compared’
to the HAQ-DI, individualized scales did not have better sensitivity to change (standardized response mean: 0.64 to 0.69 vs. 0.74).
Conclusion
Individualized scales have similar properties as the HAQ-DI. However, individualized questionnaires measuring importance gave
complementary information to the measure of disability. Therefore, even if individualization is probably not needed for group
assessment in all randomized controlled trials, the use of individualized questionnaires could be clinically relevant for individual RA
patients.
MESH Keywords Activities of Daily Living ; Aged ; Antirheumatic Agents ; therapeutic use ; Arthritis, Rheumatoid ; drug therapy ; physiopathology ; rehabilitation ; 
Disability Evaluation ; Female ; Humans ; Isoxazoles ; therapeutic use ; Male ; Middle Aged ; Prospective Studies ; Psychometrics ; Reproducibility of Results ; Severity of
Illness Index ; Treatment Outcome
Author Keywords Health assessment questionnaire ; Rheumatoid arthritis ; Patient-specific index ; Individualization ; Patient reported outcome ; Patient s perspective'
Outcome assessment in rheumatoid arthritis (RA) was primarily based on physician-reported outcomes such as measures of disease
activity  or structural progression. ,  However, symptoms such as pain, fatigue and disability are relevant and their assessment is[1 –3 ] [4 5 ]
recommended for evaluation of response to treatment.  The Health Assessment Questionnaire Disability Index (HAQ-DI) is a valid,[6 ]
reliable, and widely used tool to measure functional status in RA patients.  It is a standardized questionnaire, identical for all[7 –10 ]
patients, investigating patients  ability to perform some activities, as well as the importance of being able to perform each activity.’
However, these issues may vary widely among individuals. Furthermore, enhancing patients  perspectives in RA outcome assessment was’
noted as a major focus for research. , [6 11 ]
For these reasons, patient-specific, or individualized, scales have been developed to address each patient s priorities in outcome’
assessment in RA.  Some have been shown to be more sensitive to change than classical instruments.  However, most of[12 –15 ] [16 –18 ]
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them involve semi-structured interviews requiring 15 to 40 minutes to complete.  Hewlett et al. developed an individualized[19 ]
questionnaire derived from the modified HAQ, ,  where each item is weighted by the importance it has for each patient. However,[20 21 ]
responsiveness of the scale has not been evaluated.
We designed this prospective study to develop, validate and evaluate psychometric properties of patient-specific scales, assessing the
level of disability in RA patients, derived from the HAQ-DI according to several methods of individualization.
PATIENTS AND METHODS
Study population
Data were obtained from a 6-month, prospective, open-label study involving 378 RA outpatients treated with leflunomide.[22 ]
Patients included had RA as defined by the American Rheumatism Association revised criteria,  with active disease defined by a[23 ]
physician global assessment of disease activity 2 on a 5-point Likert scale (from 1 to 5). Two visits were scheduled, one at baseline≥
before initiation of leflunomide and one 6 months later.
Measurement
At baseline and final visits, patients completed:
The French version of the HAQ-DI,  termed the . It comprises 20 items, referring to ability in performing[24 ] severity questionnaire 
daily life activities, involving 8 domains and includes a help and device  component. For each item, score ranged from 0 to 3. The score of“ ”
each domain is the highest item score of that domain, unless help or a device is required. Dependence on help and device increases a lower
score to 2. The overall score is the mean of the 8 domain scores and varies from 0 to 3.
The : patients had to rate the importance of each HAQ-DI item, by answering the question In your daily life,importance questionnaire “
the following activity is . Importance was rated by a 4-point Likert scale, ranging from 0 not important  to 3 extremely important .…” =“ ” =“ ”
The : patients had to select and order the 5 activities (i.e. HAQ-DI items) they considered the most importantpreference questionnaire 
in their daily lives.
The swollen and tender joint counts, erythrocyte sedimentation rate (ESR), level of C-reactive protein (CRP) were also collected to
obtain the disease activity score (DAS28).
Methods of individualization
Several individualized scales were obtained:
Scales based on the importance questionnaire
With multiplicative, or additive, methods: for each item, the severity score was multiplied by, or added to, the importance score.
The score for each domain was the highest score obtained after combining the severity and importance scores of items of that domain.
The total score was the mean score of all 8 domains. Individualized scale, with multiplicative method, preserving all 20 items was also
obtained.[25 ]
Scales based on the preference questionnaire.
Top 5 HAQ: involving only the 5 most important activities for each patient.
Weighted top 5 HAQ: involving only the 5 most important activities, whereby the severity score is weighted by the rank of preference
for this activity (highest weight referred to the most important activity).
In these scales, the resulting items are not the same for all patients. The total score was the sum of the scores, weighted or not, of the 5
most important items.
Initial scores were obtained by combining data from the baseline visit. Final scores were obtained by combining baseline importance
or preference ratings and final severity scores. Because the rating of importance has not been applied to the help and device component,
individualized scales were developed without this component. Each scale was linearly transformed to a scale of 0 to 3; 0 indicating no
disability and 3 indicating maximal possible disability.
Statistical analysis
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All patients who had completed the original HAQ-DI with no missing data at baseline were involved in the development of
individualized forms. Psychometric properties of each individualized scale were evaluated, and compared to that of the HAQ-DI:
Construct validity was assessed by Spearman rho correlation between the score of each individualized scale and that of the HAQ-DI.
We also examined divergent validity using Spearman correlation between scores of individualized scales and other measures of disease
activity (swollen and tender joint count, ESR, CRP level and DAS28).
Internal consistency was assessed, when estimable (i.e. for scales with identical items), by Cronbach s alpha coefficient.’ [26 ]
Estimation of confidence intervals and comparisons of Cronbach s alpha coefficients involved the bootstrap method, with 1000’
replications.[27 ]
Responsiveness was assessed by the standardized response mean (SRM), which is the mean change in score between baseline and final
visit divided by the standard deviation of the change in score.  SRM values can be considered large (>0.8), moderate (0.5 0.8) or small[28 ] –
(<0.5). ,  SRM confidence interval estimations and SRM comparisons involved the bootstrap method with 1000 replications.[29 30 ] [27 ]
Statistical analysis involved use of SAS, release 9.1 (SAS Inst., Cary, NC), and R, release 2.2.1 (The R Foundation for Statistical
Computing, Vienna, Austria).
RESULTS
Of the 378 outpatients with RA enrolled in the study, 370 (98 ) completed the HAQ-DI without missing data at baseline ( ).% table 1 
Among them, 360 (95 ) and 281 (74 ) patients correctly completed the importance and preference questionnaires, respectively.% %
For each item, severity and importance scores were weakly or not significantly correlated (rho ranging from 0.01 to 0.29) ( ).table 2 
Plots of severity by importance scores revealed that patients with the highest severity scores for items did not necessarily grade the items
as important and patients with the lowest severity score for items did not necessarily consider the items as not important ( ). As forfigure 1 
item get on and off the toilet , 71  (124/175) of the not disabled patients (severity score of 0) considered this activity as important or“ ” %
extremely important. At the baseline, based on the preference questionnaire, the 3 most important items were dress yourself  (86 ), wash“ ” % “
and dry entire body  (63 ), and walk outdoors on flat ground  (55 ). Data collected by the importance questionnaire also showed that” % “ ” %
each of these 3 activities was considered important or extremely important by more than 75  of the patients. At final visit, no change in%
selection of the 5 most important items was observed for 17  of patients, whereas 34  (61/182) and 66  (121/182) of patients selected at% % %
least 4 and 3, respectively, of the initial 5 items they chose.
Construct validity
All individualized scale scores were highly correlated with the HAQ-DI score (rho 0.75; ). Lower correlations were observed≥ table 3 
with measures of disease activity: tender and swollen joint counts (rho ranging from 0.21 to 0.39) and DAS28 (rho ranging from 0.38 to
0.47). The lowest correlations were observed with biological features of disease activity, such as ESR and CRP level (rho ranging from
0.10 to 0.18).
Internal consistency
For scales with 8 domains, Cronbach s alpha coefficient ranged from 0.87 to 0.88 ( ). Scales preserving all 20 items had higher’ table 3 
Cronbach s alpha coefficients (alpha 0.94).’ =
Responsiveness
The SRM of the HAQ-DI was 0.74, compared to 0.69 without help and device component (p<0.05). SRMs of individualized scales
ranged from 0.64 to 0.69 ( ). SRM of scales preserving all 20 items was 0.66.table 3 
DISCUSSION
This study evaluated the interest of individualizing the HAQ-DI to measure disability in RA patients. Individualized scales have
similar psychometric properties as the parent HAQ-DI, whatever the individualization method used. However, adding a measure of “
importance  to a measure of severity  for each activity provided complementary information that could be clinically useful in decision” “ ”
making for individual patients.
Many studies have shown divergent views of a patient s health between patients and clinicians.  So far, the use of’ [31 –33 ]
patient-reported outcomes and inclusion of patients  opinions in their development has gradually increased.  One usual approach to’ [34 ]
incorporate patients  opinion in development of patient-reported outcomes is to determine, in a group of patient, the importance of each’
item and to weight that item with the mean importance score at group level. However, such a group approach assumes concordance of all
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patients  views. To facilitate patient input into the assessment process, individualized measured has been proposed. Two key practices are’
recommended for individualization:  (i) to incorporate patients  rating of importance in addition to severity for each item, and/or (ii) to[35 ] ’
augment the instrument with supplemental items that patients can add. Our study relies on the first recommendation, and used 2 methods.
The first method combined, for each item, the rating of severity  and importance . In the second method, each patient selected a limited“ ” “ ”
number of items he considered the most important. Moreover, both methods were combined, by ranking the importance of these most
important items. Regarding the second recommendation, our study unfortunately, did not offer patients the opportunity to provide
supplemental relevant items, not contained in the HAQ-DI.[31 ]
Arguing that importance of an activity is closely related to level of disability in performing that activity, some authors wonder whether
assessment of disability alone could be sufficient. ,  Against this hypothesis, our resulted showed that for most items, rating of[36 37 ]
importance and level of disability were weakly correlated. Moreover, as previously shown, ratings of the importance were extremely
variable among patients with similar levels of disability, but were also similar among patients with diverse levels of disability. , [20 38 ]
So, individualized approach may be useful in clinical practice to help physician to prioritize care on what is really meaningful to each
patient.
In our previous study evaluating individualized forms of the WOMAC function subscale, ratings of the importance and severity of
each item were strongly correlated;  furthermore, the individualized scale retaining the 5 most important activities was more sensitive[38 ]
to change than the parent scale. In that study, patients were asked to define activities that were the most in need of improvement. In the
present study, the wording was slightly different, and patients had to define importance of activities of their daily lives, even though they
had no difficulty performing them. As shown for item get on and of the toilet , with this wording, it is likely that important items for a“ ”
patient may be those that are relevant to him, but perhaps easier to do. Therefore, if these items are initially close to normal, improvement
is not possible. Items are therefore less sensitive to change. This difference might explain the discrepancies between results of these
studies.
As previously proposed, ,  we also used the HAQ-DI without the help and devices component, but found it less sensitive to[25 39 ]
change than the parent HAQ-DI. Because the rating of importance was not applied to the help and devices component, individualized
scales did not include this component. This omission could have explained in part why the individualized scales had lower responsiveness
than the parent HAQ-DI.
Individualized scales derived from the HAQ-DI did not have better responsiveness than the parent HAQ-DI. This could be explained
by the wording of the individualized questionnaire that did not focus on activities in need of improvement, and by the scoring method of
the HAQ-DI, somewhat already individualized considering for each domain the activity for which the patient is most disabled. However,
the measure of importance of an activity gave complementary information to the measure of disability. Therefore, even if individualization
is probably not needed for group assessment in all randomized controlled trials, the use of individualized questionnaires could be clinically
relevant in decision making for individual patients.
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Figure 1
Patterns of plots of scores of severity by importance for 3 of the 20 HAQ-DI items
These graphics represent patterns of plots of severity scores against importance scores. The area of each point is proportional to the number of
patients. Plots showed that patients with the highest severity scores for items did not necessarily grade the items as important (item 13: Reach“
and get down a 5 lb object ) and patients with the lowest severity score for items did not necessarily consider the items as not important (item”
1 and 12: Dress yourself  and Get on and off the toilet ).“ ” “ ”
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Table 1
Baseline characteristics of patients
Patients with complete data for HAQ-DI Patients with complete data for all scores
N 370= N 281=
Age (years) 58.37  11.93± 58.13  11.87±
Sex (female) 292 (78.92 )% 225 (80.07 )%
Rheumatoid factor positive 248 (66.85 )% 174 (61.92 )%
Disease duration (years) 9.84  8.49± 9.34  8.25±
Prior DMARD intake 325 (87.84 )% 243 (86.48 )%
Patient global assessment of disease activity 52.41  19.08± 52.82  19.53±
Physician global assessment of disease activity 51.58  17.11± 51.63  17.12±
Swollen joint count (/28) 9.78  5.70± 9.51  5.76±
Tender joint count (/28) 12.02  6.58± 11.98  6.66±
ESR (mm) 30.14  22.25± 30.46  21.81±
CRP level (mg/L) 23.43  30.80± 23.64  31.03±
DAS28 5.62 1.10± 5.62  1.11±
HAQ-DI 1.40  0.62± 1.41  0.61±
Range 0.00 2.87[ – ] Range 0.12 2.75[ – ]
Data are presented as mean  SD or n ( )± %
DAS: disease activity score; DMARD: disease-modifying anti-rheumatic drug; ESR: erythrocyte sedimentation rate; HAQ-DI: health assessment questionnaire disability index; CRP: C-reactive protein
Table 2
Importance of each activity of the HAQ-DI from the patient s perspective’
Domain Item
Severity
Questionnaire
Importance
Questionnaire
Correlation between
severity and importance
Preference Questionnaire
Mean baseline
disability (n 370)=
Mean baseline
importance (n 360)=
Items selected at
baseline visit (n 274)=
Items selected at both baseline
and final visits (n 182)=
Identical items selected at baseline
and at final visit (n 182)=
Dressing and grooming
Dress yourself 1.07 0.76 ± 2.14 0.80 ± 0.15 234 (86 )% 124 (68 )% 142 (78 )%
Shampoo your hair 0.95 0.89 ± 1.89 0.91 ± 0.24 37 (14 )% 7 (4 )% 156 (86 )%
Arising
Stand from a chair 0.68 0.67 ± 1.95 0.90 ± 0.11 73 (27 )% 26 (14 )% 143 (79 )%
Get in and out of bed 0.74 0.71 ± 2.01 0.90 ± 0.10 74 (27 )% 24 (13 )% 140 (77 )%
Eating
Cut your meat 0.95 0.84 ± 1.95 0.88 ± 0.22 86 (31 )% 26 (14 )% 132 (73 )%
Lift a full cup or
glass to mouth
0.60 0.72 ± 1.92 0.92 ± 0.14 57 (21 )% 16 (9 )% 145 (80 )%
Open a new carton
of milk
1.41 0.93 ± 1.83 0.87 ± 0.20 16 (6 )% 3 (2 )% 167 (92 )%
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Walking
Walk outdoors on
flat ground
0.74 0.69 ± 2.01 0.93 ± 0.22 150 (55 )% 66 (36 )% 123 (68 )%
Climb 5 steps 0.84 0.75 ± 2.04 0.88 ± 0.17 34 (12 )% 6 (3 )% 154 (85 )%
Hygiene
Wash and dry entire
body
0.85 0.77 ± 2.18 0.91 ± 0.14 172 (63 )% 97 (53 )% 135 (74 )%
Take a bath 1.16 1.05 ± 1.87 1.01 ± 0.01 43 (16 )% 13 (7 )% 148 (81 )%
Get on and off the
toilet
0.59 0.67 ± 2.08 0.99 ± 0.07 75 (27 )% 32 (18 )% 133 (73 )%
Reach
Reach and get down
a 5-lb object
1.68 0.97 ± 1.77 0.88 ± 0.13 45 (16 )% 13 (7 )% 148 (81 )%
Bend down and pick
up clothing
0.82 0.76 ± 1.79 0.89 ± 0.23 18 (7 )% 6 (3 )% 166 (91 )%
Grip
Open car doors 0.75 0.74 ± 1.70 0.89 ± 0.17 24 (9 )% 4 (2 )% 165 (91 )%
O p e n  j a r s
(previously opened)
1.13 0.87 ± 1.82 0.83 ± 0.25 26 (9 )% 8 (4 )% 165 (91 )%
Turn taps on and off 0.94 0.75 ± 2.04 0.85 ± 0.29 34 (12 )% 8 (4 )% 155 (85 )%
Other activities
Run errands and
shop
0.86 0.85 ± 1.87 0.91 ± 0.14 89 (32 )% 36 (20 )% 114 (63 )%
Get in and out of car 0.73 0.69 ± 1.83 0.92 ± 0.21 31 (11 )% 4 (2 )% 158 (87 )%
Do chores 1.31 0.88 ± 1.87 0.89 ± 0.09 87 (32 )% 41 (23 )% 151 (83 )%
Data are presented as mean  SD or n ( )± %
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Table 3
Psychometric properties of classical HAQ-DI and individualized HAQ scales
HAQ-DI Importance questionnaire Preference questionnaire
Individualized HAQ multiplicative Individualized HAQ additive 5-item HAQ Weighted 5-item HAQ
Mean baseline score 1 1.40  0.62± 0.92  055± 1.70  0.46± 1.01  0.64± 1.03  0.66±
Mean change in score 1 −0.41  0.55± −0.30  0.44± −0.19  0.28± −0.38  0.59± −0.39  0.61±
Construct validity
Spearman s correlation with HAQ-DI score’ 1 0.88 0.77 0.77 0.76
Internal consistency
Cronbach s alpha 95  CI’ [ % ] 0.87 0.85 0.89[ – ] 0.88 0.85 0.90[ – ] 0.88 0.86 0.90[ – ] NE NE
Sensitivity to change
SRM 95  CI[ % ] 0.74 0.64 0.86[ – ] 0.69 0.58 0.79[ – ] 0.68 0.58 0.80[ – ] 0.65 0.55 0.77[ – ] 0.64 0.54 0.76[ – ]
1 Data are presented as mean  SD.±
HAQ-DI: health assessment questionnaire disability index; NE: not estimable; SRM: standardized response mean.
Each score was linearly transformed to a score from 0 to 3.
Mean changes in scores were calculated between the baseline visit at week 0 (W0) and the final visit at week 24 (W24): W24-W0.
For Spearman s correlations, all p-values were <0.0001.’
95  CI : 95  confidence intervals were estimated by the bootstrap method with 1000 replications.[ % ] %
